A
$ Value
$603
Shares
24
Price
$25
Filed
Aug 19
Insider
Name
BOURLA ALBERT
Title
Chairman & CEO
CIK
0001595703
Roles
Director
Officer
Transaction Details
Transaction Date
2025-08-15
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
730,477
Footnotes
Each unit represents one phantom share of common stock. | These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Filing Info
BOURLA ALBERT's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-15 | PFE | A | $598 |
| 2026-04-14 | PFE | A | $25K |
| 2026-03-31 | PFE | A | $590 |
| 2025-10-15 | PFE | A | $610 |
| 2025-10-14 | PFE | A | $2K |
| 2025-09-30 | PFE | A | $612 |
| 2025-09-15 | PFE | A | $599 |
| 2025-08-29 | PFE | A | $594 |
| 2025-08-15 | PFE | A | $603 |
| 2025-07-31 | PFE | A | $606 |
Other Insiders at PFE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| NARAYEN SHANTANU | — | — | 2026-03-27 |
| Taraporevala Cyrus | — | — | 2026-03-27 |
| Quincey James | — | — | 2026-03-27 |
|
BOURLA ALBERT
Chairman & CEO
|
— | — | 2026-04-15 |
| SMITH JAMES C | — | — | 2026-03-27 |
| Echevarria Joseph | — | — | 2026-03-27 |
| Buckley Mortimer J | — | — | 2026-03-27 |